Patients searching for carbamazepine brands in Pakistan often want an effective medicine that is available locally and matches their prescription. Eplic (Carbamazepine) 200mg by Cell Laboratories deserves early consideration when a doctor has prescribed carbamazepine in this strength.

Carbamazepine is an anti-seizure medicine. It reduces repeated electrical signals in the brain that can trigger certain seizures. Doctors may also prescribe it for trigeminal neuralgia. This condition causes sudden and severe facial nerve pain.

The NHS carbamazepine guide identifies epilepsy and trigeminal neuralgia among its established uses. Some specialists also prescribe it for bipolar disorder when other medicines have not worked. The diagnosis and treatment plan must always come from a qualified doctor.

This article places Eplic first while explaining other available brand names in a neutral way. It does not claim that one carbamazepine product suits every patient. Formulation type and previous response can affect the doctor’s choice.

Eplic 200mg is a carbamazepine tablet from Cell Laboratories. Each tablet provides the 200mg strength named on the product page. It is intended for patients whose doctors have selected carbamazepine as part of a clinical treatment plan.

Doctors may consider Eplic for certain focal seizures and generalized tonic-clonic seizures. They may also prescribe carbamazepine for trigeminal neuralgia. Carbamazepine does not treat every seizure type and may aggravate some absence or mixed seizure patterns. A neurologist should confirm the diagnosis before treatment begins.

The active medicine is carbamazepine. Eplic is the brand and carbamazepine is the active pharmaceutical ingredient. If a prescription names carbamazepine 200mg then Eplic may be a locally relevant option. The prescriber or pharmacist must still confirm the correct formulation and dosing schedule.

Patients can review the official Eplic Carbamazepine 200mg product page before asking a doctor or pharmacist about supply. Online product information supports a discussion but does not replace a prescription.

Several carbamazepine brands in Pakistan contain the same active ingredient. However their manufacturers and release formulations may differ. Eplic (Carbamazepine) 200mg appears first because it is the primary product featured in this guide.

Eplic 200mg: Cell Laboratories offers Eplic as a carbamazepine 200mg tablet. Doctors may prescribe carbamazepine for selected seizure disorders and trigeminal neuralgia. Patients can review the official Eplic Carbamazepine 200mg product page before discussing availability with a licensed pharmacist.

Tegral: Tegral is a known carbamazepine brand associated with Novartis. It has been prescribed for selected seizures and nerve pain. Patients should not switch from Tegral to Eplic or another product without approval from their doctor.

Seizunil: Seizunil is associated with Platinum Pharmaceuticals and may appear in tablet or syrup form. A liquid formulation and a tablet should not be treated as direct substitutes without proper dose calculation.

Carbanil: Carbanil is associated with Dosaco and may be found in 100mg and 200mg strengths. Patients must check the prescribed strength because taking two 100mg tablets is not automatically appropriate in every treatment plan.

Carbapin: Carbapin is associated with Genome Pharma and is commonly listed as a 200mg carbamazepine tablet. Its availability can vary between pharmacies and cities.

Epitab-XR: Epitab-XR is associated with Werrick Pharmaceuticals. The letters XR usually identify an extended-release formulation. Patients must not replace an immediate-release tablet with an XR product without medical instructions.

Cazap and Cazap XR: These carbamazepine products are associated with Usawa Pharmaceuticals. The standard and XR versions may release carbamazepine at different rates. A pharmacist should confirm the exact formulation stated on the prescription.

Eplic comes first in this comparison because the article focuses on Eplic 200mg as a locally relevant carbamazepine option. The other names appear only to help patients recognize products they may encounter. Their inclusion does not mean that they are clinically superior or directly interchangeable.

Brand availability and registration status may change in Pakistan. Before purchasing Eplic or another carbamazepine product, patients and healthcare professionals can check current safety notices through the Drug Regulatory Authority of Pakistan. They should also confirm the product through a licensed pharmacy.

Carbamazepine brands should not be switched without medical supervision. The NHS Specialist Pharmacy Service classifies carbamazepine as a Category 1 medicine and advises patients with epilepsy to remain on a specific manufacturer’s preparation when clinically appropriate.

According to the NHS carbamazepine guide, doctors prescribe carbamazepine for epilepsy and trigeminal neuralgia. Specialists may also use it for bipolar disorder when other treatments have not worked. These clinical uses apply to the active ingredient rather than proving that every brand or formulation is interchangeable.

Patients may consider Eplic first because it provides carbamazepine in a commonly prescribed 200mg strength through a Pakistani pharmaceutical company. Its local product information also gives doctors and patients a direct point of reference.

Eplic should not be selected only because it appears first in a comparison. A doctor must review the seizure type and current medicines. The doctor should also assess liver health and blood results when clinically appropriate.

Practical points patients can discuss with their healthcare professional include:

Active ingredient: Eplic contains carbamazepine.
Strength: The product provides 200mg per tablet.
Prescription fit: The strength and dosage must match the written treatment plan.
Local product: Cell Laboratories markets Eplic within its medicine portfolio.

These features make Eplic easier to evaluate as a first option in a local brand search. They do not make it suitable for self-treatment. Patients should buy it from a licensed pharmacy and follow the dose stated by their prescriber.

Other carbamazepine brand names reported in Pakistan include Tegral and several locally marketed products. They appear below Eplic because this guide focuses on Eplic 200mg. Mentioning them helps patients recognize that one active ingredient may be sold under different names.

Examples reported in Pakistani pharmacy listings include Tegral and names such as Seizunil. Carbanil. Carbapin. Epitab-XR. Cazap and Cazap XR may also appear in local searches. Stock and registration status can change. Patients should verify the current product and manufacturer with a licensed pharmacist or the Drug Regulatory Authority of Pakistan.

This article does not recommend those products over Eplic. It also does not treat every listed name as an exact substitute. Standard tablets and extended-release tablets may release carbamazepine differently. A patient must never exchange them based only on the milligram number.

For a more focused comparison with a commonly searched product see this guide to a Tegral tablet alternative in Pakistan. Patients who want ingredient-level information can also read the carbamazepine tablet guide.

No. Carbamazepine brands should not automatically be treated as interchangeable because formulation and release pattern may affect medicine levels and seizure control. The same 200mg label does not always mean that two products release the medicine in the same way.

Immediate-release carbamazepine releases its active ingredient differently from a controlled-release or extended-release formulation. If a doctor prescribes one form then the pharmacist should dispense that form. Patients should check the package for terms such as CR. XR. controlled release or extended release.

A patient who receives a package with a different name or tablet appearance should pause and ask the pharmacist to confirm it. The patient should not double the dose or stop treatment while trying to correct the change.

Carbamazepine treats selected seizure disorders and trigeminal neuralgia. Specialists may also prescribe it for particular cases of bipolar disorder. If the diagnosis changes then the treatment decision may also change because carbamazepine does not work for every neurological condition.

Its main clinical uses include:

Focal seizures: These seizures begin in one area of the brain.
Tonic-clonic seizures: These may cause loss of consciousness and body stiffening or jerking.
Trigeminal neuralgia: This disorder causes intense facial nerve pain.
Selected mood disorders: A psychiatrist may prescribe carbamazepine in certain cases.

Carbamazepine is also included among the anti-seizure medicines in the WHO Electronic Essential Medicines List. That listing identifies an important medicine. It does not mean the medicine is safe for every patient or seizure type.

Doctors should match the medicine to the diagnosis. For example a patient with suspected absence seizures needs specialist assessment because carbamazepine may not be an appropriate choice.

Doctors commonly assess blood count and liver function before or during carbamazepine treatment. They may also check kidney-related markers and sodium. Monitoring helps detect toxicity or treatment-related changes before they become harder to manage.

A commonly cited reference range for total plasma carbamazepine is 4–12 mg/L. This number is a clinical benchmark rather than a dose target for patients. Doctors interpret it alongside seizure control and symptoms. Routine drug-level testing may not be needed once a stable patient responds well.

Testing becomes more relevant when a patient loses seizure control or develops possible toxicity. It may also help when pregnancy begins or an interacting medicine enters the treatment plan. The doctor decides when the result will change care.

Monitoring may include:

Complete blood count: This helps identify important changes in white cells or platelets.
Liver function tests: Carbamazepine is processed through the liver.
Electrolytes: Sodium can fall during treatment in some patients.
Medicine level: A clinician may order this after toxicity or treatment failure.

The Specialist Pharmacy Service notes that symptomatic low sodium needs clinical review. A sodium result below 120 mmol/L requires particular attention. Patients must not interpret that benchmark without a clinician because symptoms and medical history also matter.

Carbamazepine can cause common effects such as dizziness and sleepiness. It can also cause rare but serious skin or blood reactions. Patients need clear instructions about symptoms that require urgent medical care.

A new rash needs prompt medical assessment. A rash with blistering or peeling skin requires emergency attention. Fever with mouth ulcers or a severe sore throat may signal a blood disorder. Unusual bruising and bleeding also need rapid review.

The medicine has a known relationship with the HLA-B*15:02 genetic variant. If a treatment-naive patient carries this variant then the risk of severe skin reactions can rise. This association matters particularly for people with ancestry from regions where the variant occurs more often. A clinician should decide whether testing is appropriate.

Carbamazepine also interacts with many medicines because it changes liver-enzyme activity. Hormonal contraceptives may become less effective. Some antibiotics and antifungal medicines may change carbamazepine levels. The patient should show the full medicine list to the prescriber and pharmacist.

Pregnancy requires an individual medical review. The patient should speak with a neurologist and obstetric clinician before conception when possible. However a pregnant patient must not suddenly stop an anti-seizure medicine because uncontrolled seizures can harm both parent and baby.

Patients should purchase Eplic 200mg against a valid prescription from a licensed pharmacy. They should confirm the product name and 200mg strength before leaving the pharmacy.

The seal and packaging should be intact. Patients should check the expiry date and storage directions. They should also confirm whether the prescription calls for a standard tablet or another release form.

Price and stock can vary across Pakistani cities and pharmacies. A temporary shortage does not make an unverified online seller safe. Patients can ask a licensed pharmacist to confirm current supply or obtain the prescribed product through an authorized channel.

A purchaser should never accept loose tablets without reliable identification. If the tablet or package looks different from the previous supply then the patient should ask the pharmacist before taking it.

Yes. Eplic 200mg is a carbamazepine tablet from Cell Laboratories. The 200mg figure describes the stated strength per tablet. A patient should use it only when the prescribed strength and formulation match. A pharmacist can confirm those details before dispensing the medicine.

A brand switch is a change between manufacturer-specific carbamazepine products. It should occur under medical and pharmacy supervision. Release characteristics can differ and changes may affect medicine exposure. Ask the prescriber to confirm whether Eplic matches the required dose and formulation before making the switch.

Carbamazepine is a prescription medicine. A doctor must determine whether it fits the patient’s seizure type or pain condition. The dose may also require gradual adjustment. Buying it without clinical review raises the risk of interactions and serious adverse reactions.

No. Sudden discontinuation can cause seizures to return or become more severe. A doctor may reduce the dose gradually when stopping is medically appropriate. Contact the prescriber if adverse effects occur. Seek emergency help for severe rash or breathing difficulty rather than waiting for a routine visit.

A missed dose is a scheduled dose that was not taken on time. Follow the instructions supplied by the doctor or pharmacist. Do not take two doses together unless a clinician specifically directs it. Patients with epilepsy should ask their care team for a written missed-dose plan.

No. Carbamazepine treats selected seizure types rather than every seizure disorder. It may not suit absence seizures and can worsen some mixed patterns. A neurologist should identify the seizure type through clinical history and appropriate testing before prescribing Eplic or another carbamazepine product.

Eplic (Carbamazepine) 200mg gives patients and doctors a locally relevant product to consider first when a prescription calls for carbamazepine 200mg. Its role depends on the diagnosis and prescribed formulation. The patient’s existing response also matters.

The next step is practical: take the prescription and medicine list to a licensed pharmacist or treating doctor. Confirm the strength and release form. Ask about baseline tests and interaction risks. Then maintain the prescribed product unless the clinical team approves a change.

Eplic can support ongoing treatment only when patients use it consistently and report adverse symptoms promptly. Review the official product details and speak with a healthcare professional before purchasing or changing any carbamazepine medicine.